113 related articles for article (PubMed ID: 22356668)
1. Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.
Carpentier PJ; Knapen LJ; van Gogh MT; Buitelaar JK; De Jong CA
J Addict Dis; 2012; 31(1):45-59. PubMed ID: 22356668
[TBL] [Abstract][Full Text] [Related]
2. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.
Carpentier PJ; van Gogh MT; Knapen LJ; Buitelaar JK; De Jong CA
Eur Addict Res; 2011; 17(1):10-20. PubMed ID: 20881401
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
5. [Addiction from a developmental perspective: the role of conduct disorder and ADHD in the development of problematic substance use disorders].
Carpentier PJ
Tijdschr Psychiatr; 2014; 56(2):95-105. PubMed ID: 24535766
[TBL] [Abstract][Full Text] [Related]
6. [Psychopathology associated to attention deficit hyperactivity disorder in school age children].
Ulloa RE; Sánchez S; Sauceda JM; Ortiz S
Actas Esp Psiquiatr; 2006; 34(5):330-5. PubMed ID: 16991022
[TBL] [Abstract][Full Text] [Related]
7. Attention deficit hyperactivity disorder and severity of substance use: the role of comorbid psychopathology.
Torok M; Darke S; Kaye S
Psychol Addict Behav; 2012 Dec; 26(4):974-9. PubMed ID: 22486329
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
Babcock T; Ornstein CS
Postgrad Med; 2009 May; 121(3):73-82. PubMed ID: 19491543
[TBL] [Abstract][Full Text] [Related]
9. Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD).
Turgay A
Essent Psychopharmacol; 2005; 6(5):277-90. PubMed ID: 16222912
[TBL] [Abstract][Full Text] [Related]
10. Conduct disorder subtype and comorbidity.
Connor DF; Ford JD; Albert DB; Doerfler LA
Ann Clin Psychiatry; 2007; 19(3):161-8. PubMed ID: 17729017
[TBL] [Abstract][Full Text] [Related]
11. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
[TBL] [Abstract][Full Text] [Related]
12. History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled study.
Davids E; von Bünau U; Specka M; Fischer B; Scherbaum N; Gastpar M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):291-6. PubMed ID: 15694237
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
Pliszka SR
J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
[TBL] [Abstract][Full Text] [Related]
14. Neuroanatomical correlates of attention-deficit-hyperactivity disorder accounting for comorbid oppositional defiant disorder and conduct disorder.
Sasayama D; Hayashida A; Yamasue H; Harada Y; Kaneko T; Kasai K; Washizuka S; Amano N
Psychiatry Clin Neurosci; 2010 Aug; 64(4):394-402. PubMed ID: 20546170
[TBL] [Abstract][Full Text] [Related]
15. Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study.
Monuteaux MC; Faraone SV; Michelle Gross L; Biederman J
Psychol Med; 2007 Dec; 37(12):1731-41. PubMed ID: 17451627
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
Ghanizadeh A
J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
[TBL] [Abstract][Full Text] [Related]
17. Impact of behavioral/developmental disorders comorbid with conduct disorder.
Harada Y; Hayashida A; Hikita S; Imai J; Sasayama D; Masutani S; Tomita T; Saitoh K; Washizuka S; Amano N
Psychiatry Clin Neurosci; 2009 Dec; 63(6):762-8. PubMed ID: 20021630
[TBL] [Abstract][Full Text] [Related]
18. Risperidone in comorbid ADHD and ODD/CD.
Kewley GD
J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1327-8. PubMed ID: 10560215
[No Abstract] [Full Text] [Related]
19. Attention-deficit/hyperactivity disorder: a selective overview.
Biederman J
Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
